Sponsorship Statement: This continuing medical education activity is jointly sponsored by
and 
Support Statement: This activity is supported by an educational grant from 
Target Audience: The intended audience for this activity is ophthalmologists and other healthcare professionals involved in the treatment of patients with vitreoretinal disorders.
Learning Objectives: After reviewing the material, the participant should be able to:
- Discuss the current clinical evidence for the most appropriate use of intravitreal anti-VEGF agents in the treatment of DME, to ensure these patients receive optimal therapy.
- Evaluate potential therapies for DME, based on recent clinical studies, to allow for adoption of a flexible and effective approach to management of the disease.
Course Chair:
Carmen A. Puliafito, MD, MBA
Retina/Vitreous Section Editor
Ocular Surgery News®
OSN Retina: Chief Medical Editor
Dean, Keck School of Medicine
Professor of Ophthalmology and Health Management
May S. and John Hooval Dean’s Chair in Medicine
University of Southern California
Los Angeles, CA
Faculty:
Michael S. Ip, MD
OSN Retina: Associate Medical Editor
Associate Professor
Department of Ophthalmology and Visual Sciences
University of Wisconsin
School of Medicine and Public Health
Madison, WI
Andrew P. Schachat, MD
Vice Chairman
Cole Eye Institute
Cleveland Clinic
Professor of Ophthalmology
Lerner College of Medicine
Cleveland, OH
Accreditation:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Vindico Medical Education and Ocular Surgery News®. Vindico Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, April 25, 2012 to April 25, 2013.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, read the articles, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
Planning Committee and Faculty:
Carmen A. Puliafito, MD, MBA
Michael S. Ip, MD
Andrew P. Schachat, MD
External Reviewer:
Mitchell Goff, MD
Medical Writer:
Valerie Zimmerman, PhD
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Planning Committee and Faculty members report the following relationship(s):
Michael S. Ip, MD
Consulting Fees: Alimera, Allergan, Genentech, NicOx, Sirion
Contracted Research: Allergan
Carmen A. Puliafito, MD, MBA
Grant/Research Support: Zeiss Meditec
Andrew P. Schachat, MD
No relevant financial relationships to disclose
External Reviewr reports the following relationship(s):
Mitchell Goff, MD
No relevant financial relationships to disclose
Medical Writer reports the following relationship(s):
Valerie Zimmerman, PhD
No relevant financial relationships to disclose
Vindico Medical Education and Ocular Surgery News® staff report the following relationship(s):
No relevant financial relationships to disclose
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2012 SLACK Incorporated®. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education and Ocular Surgery News® continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education and Ocular Surgery News®. Neither Vindico Medical Education, Ocular Surgery News®, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.